Home » Newsletters » BioWorld Science

BioWorld Science

March 4, 2010

View Archived Issues

alpha2A-Adrenoceptor gene polymorphism and overexpression linked to type 2 diabetes

Prostanoid DP receptor antagonist AMG-853 safe in humans

Bepreve reduces allergen-induced ocular itching, nasal congestion and rhinorrhea in phase III trials

XF-73 and XF-70 active against pathogens relevant to biodefense

Submicron budesonide formulation may innovate pediatric asthma treatment

Vaccination with autologous HIV-1-pulsed DCs feasible in HIV

Janssen presents novel dopamine and serotonin receptor antagonists

Sanofi-aventis claims new cannabinoid CB1 receptor antagonists

Boehringer Ingelheim claims novel EGFR inhibitors

Nabi stockholders approve NicVAX option and license agreement

Capstone continues phase II trial of AZX-100 in keloid scarring

Bristol-Myers Squibb and Allergan enter global agreement on ExonHit's AGN-209323

Final dose level approved in Pluristem's phase I trial of PLX-PAD

Seattle Genetics achieves milestone under antibody-drug conjugate collaboration with Genentech

Enanta nominates EDP-239 as lead development candidate for HCV

FDA approves Novo Nordisk's Norditropin FlexPro prefilled growth hormone pen

NicOx grants Bausch & Lomb worldwide rights to NCX-116

Lilly and Transition Therapeutics enter into licensing and collaboration agreement

Solasia and Kyowa Hakko Kirin license agreement for SP-01 in Asia

Lundbeck and Takeda plan phase III trials of Lu-AA21004 and Lu-AA24530

Pfizer and Medivation report phase III results on Dimebon in Alzheimer's disease

Genzyme and PTC report on phase IIb ataluren trial in nmDBMD

Chiesi identifies novel muscarinic M3 receptor antagonists

Light Sciences Oncology completes enrollment in phase III Aptocine trial in MCRC

Advanced Cell Technology's RPE cells granted FDA orphan drug status / News in Context

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...